Building proactive protection where it is needed most.

Axenic™ strives to provide healthcare organizations with advanced tools to fight against pathogens

Today’s infection prevention and control (IPC) processes do not work as effectively as they could. Axenic™ is poised to help hospitals and other healthcare settings take more proactive steps against HAIs.

Axenic™ aims to help protect the health of clinicians and healthcare providers through a combination of innovative technology, service, and products.

Our solutions are being developed to offer healthcare organizations real-time, actionable insights to help protect against many common pathogens in an effort to potentially reduce avoidable infections and further control associated costs.


Our patented Q Shield™ hand product protects against up to 99.99% of many common germs that may cause illness.


Axenic™ is building a facility treatment service that will combine real-time analysis, monitoring, and management of pathogen activity and focus on helping healthcare organizations further reduce their exposure to avoidable and costly HAIs.


Axenic™ is developing technologies that will utilize new data sources in the fight against pathogens. These technologies will arm healthcare organizations with real-time, actionable insights.


The CDC reports that 1:31 hospital patients contract an HAI.1
Each year, HAIs cost the U.S. the loss of 99,000 lives and billions of dollars2
These reports suggest that seventy percent of HAIs are preventable3
While existing measures have tried to eliminate HAIs, it is clear that the problem has not been solved.


Axenic™ Health Solutions was founded with one clear mission: identify the most innovative infection prevention solutions available in the world and deliver them to U.S. healthcare providers seamlessly and cost effectively.

Meet the Team

Todd Evans

Todd Evans

Co-Founder & CEO

Warren Skea, PhD

Warren Skea, PhD

Co-Founder & CSO

Ahmad Gaber

Ahmad Gaber

Co-Founder & CAO

David Kemp

David Kemp

VP Supply Chain

Tom Delay

Tom DeLay

Corporate Advisor